149 related articles for article (PubMed ID: 7793225)
1. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
Stinson LW; Lanier WL; Lennon RL
Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
[TBL] [Abstract][Full Text] [Related]
2. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
Bevan JC; Purday JP; Reimer EJ; Bevan DR
Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
Gyermek L; Cantley EM; Lee C
Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?
Rathmell JP; Brooker RF; Prielipp RC; Butterworth JF; Gravlee GP
Anesth Analg; 1993 Mar; 76(3):513-9. PubMed ID: 8383933
[TBL] [Abstract][Full Text] [Related]
5. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium.
Denman WT; Goudsouzian NG; Gelb C
J Clin Anesth; 1996 Mar; 8(2):113-8. PubMed ID: 8695092
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular effects of pipecuronium bromide.
Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
[TBL] [Abstract][Full Text] [Related]
9. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
Whalley DG; Lewis B; Bedocs NM
Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block.
Naguib M; Abdulatif M
Anesth Analg; 1994 Feb; 78(2):306-11. PubMed ID: 8311284
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Cashman JN; Luke JJ; Jones RM
Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
[TBL] [Abstract][Full Text] [Related]
12. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium.
Gyermek L; Cantley EM
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):600-5. PubMed ID: 7874374
[TBL] [Abstract][Full Text] [Related]
14. Variability of pipecuronium neuromuscular blockade.
Diefenbach C; Mellinghoff H; Buzello W
Acta Anaesthesiol Scand; 1993 Feb; 37(2):189-91. PubMed ID: 8383402
[TBL] [Abstract][Full Text] [Related]
15. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium.
Mortensen CR; Berg H; el-Mahdy A; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Aug; 39(6):797-801. PubMed ID: 7484037
[TBL] [Abstract][Full Text] [Related]
16. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
[TBL] [Abstract][Full Text] [Related]
18. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
[TBL] [Abstract][Full Text] [Related]
19. Intubating conditions after pipecuronium bromide: the influence of dose and time.
Azad SS; Larijani GE; Bartkowski R; Seltzer JL; Weinberger M; Marr A; Goldberg ME
J Clin Anesth; 1991; 3(3):202-6. PubMed ID: 1652264
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular and cardiovascular effects of pipecuronium.
Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
